Literature DB >> 7350291

Clinical pharmacology and efficacy of vancomycin in pediatric patients.

U B Schaad, G H McCracken, J D Nelson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7350291     DOI： 10.1016/s0022-3476(80)80347-7

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  46 in total

Review 1.  Determining the optimal vancomycin daily dose for pediatrics: a meta-analysis.

Authors:  Geisa Cristina da Silva Alves; Samuel Dutra da Silva; Virginia Paula Frade; Danielle Rodrigues; André de Oliveira Baldoni; Whocely Victor de Castro; Cristina Sanches
Journal:  Eur J Clin Pharmacol       Date:  2017-08-04       Impact factor: 2.953

Review 2.  Antibacterial-induced nephrotoxicity in the newborn.

Authors:  V Fanos; L Cataldi
Journal:  Drug Saf       Date:  1999-03       Impact factor: 5.606

Review 3.  Pharmacokinetics and administration regimens of vancomycin in neonates, infants and children.

Authors:  K A Rodvold; J A Everett; R D Pryka; D M Kraus
Journal:  Clin Pharmacokinet       Date:  1997-07       Impact factor: 6.447

4.  A population pharmacokinetic model for vancomycin in pediatric patients and its predictive value in a naive population.

Authors:  P Lamarre; D Lebel; M P Ducharme
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

5.  Constant rate infusion of vancomycin in premature neonates: a new dosage schedule.

Authors:  F Pawlotsky; A Thomas; M F Kergueris; T Debillon; J C Roze
Journal:  Br J Clin Pharmacol       Date:  1998-08       Impact factor: 4.335

6.  Pharmacokinetics of vancomycin in critically ill infants undergoing extracorporeal membrane oxygenation.

Authors:  R D Amaker; J T DiPiro; J Bhatia
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

Review 7.  Pharmacokinetic optimisation of vancomycin therapy.

Authors:  W G Leader; M H Chandler; M Castiglia
Journal:  Clin Pharmacokinet       Date:  1995-04       Impact factor: 6.447

8.  Current recommended dosing of vancomycin for children with invasive methicillin-resistant Staphylococcus aureus infections is inadequate.

Authors:  Adam Frymoyer; Adam L Hersh; Leslie Z Benet; B Joseph Guglielmo
Journal:  Pediatr Infect Dis J       Date:  2009-05       Impact factor: 2.129

Review 9.  Clinical pharmacokinetics of vancomycin.

Authors:  G R Matzke; G G Zhanel; D R Guay
Journal:  Clin Pharmacokinet       Date:  1986 Jul-Aug       Impact factor: 6.447

10.  Effects of hepatic function on vancomycin clinical pharmacology.

Authors:  N Brown; D H Ho; K L Fong; L Bogerd; A Maksymiuk; R Bolivar; V Fainstein; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1983-04       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.